Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Gross Margin (2020 - 2025)

Historic Gross Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 75.1%.

  • Burning Rock Biotech's Gross Margin rose 37000.0% to 75.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.03%, marking a year-over-year increase of 43100.0%. This contributed to the annual value of 70.25% for FY2024, which is 26700.0% up from last year.
  • Burning Rock Biotech's Gross Margin amounted to 75.1% in Q3 2025, which was up 37000.0% from 72.77% recorded in Q2 2025.
  • Burning Rock Biotech's Gross Margin's 5-year high stood at 75.1% during Q3 2025, with a 5-year trough of 63.13% in Q2 2022.
  • Over the past 5 years, Burning Rock Biotech's median Gross Margin value was 70.89% (recorded in 2021), while the average stood at 69.89%.
  • In the last 5 years, Burning Rock Biotech's Gross Margin crashed by -77700bps in 2022 and then soared by 64500bps in 2024.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Gross Margin stood at 71.52% in 2021, then decreased by 0bps to 71.2% in 2022, then dropped by -9bps to 64.51% in 2023, then increased by 10bps to 70.96% in 2024, then grew by 6bps to 75.1% in 2025.
  • Its Gross Margin was 75.1% in Q3 2025, compared to 72.77% in Q2 2025 and 73.18% in Q1 2025.